• ExtendSnacks™ are not affected by Peanut Butter recall.

St. Louis, MO - January 22, 2009 - - ExtendSnacks™, a leading brand of foods that help control blood sugar, announced that none of their products or ingredients are affected in any way by the recent peanut butter recall put into effect by the FDA. ExtendSnacks does not buy any ingredients from Peanut Corporation of America (PCA), the source of the current salmonella outbreak.

While various nutritional products containing peanut butter or peanut paste are being recalled, ExtendSnacks™ are not linked to this outbreak. This includes all of their product forms – ExtendBar™ Delights, ExtendBar™ Crunches, ExtendCrisps™ and ExtendShakes™. The FDA is maintaining a list of affected brands on its website at http://www.accessdata.fda.gov/scripts/peanutbutterrecall/index.cfm – you will not find any ExtendSnacks brands on this list.

“ExtendSnacks™ is committed to providing our customers with safe, wholesome, and quality food products now and for the future,” said company president Vijay Chauhan.

About ExtendSnacks™:

ExtendSnacks™ are manufactured and marketed by Clinical Products, LLC, headquartered in St. Louis, MO. The original ExtendBar® was invented by Dr. Francine Kaufman, former president of the American Diabetes Association; current head of the Center for Diabetes, Endocrinology and Metabolism at Childrens Hospital Los Angeles; author of Diabesity; and a distinguished professor of pediatrics at the Keck School of Medicine.

The continued mission of Clinical Products is to create great-tasting, convenient food products that help control blood sugar. ExtendSnacks™ are the only snacks clinically proven to help stabilize blood sugar for up to 9 hours, providing the benefits of hunger control and long-lasting energy.

ExtendBar® is available at Walgreens stores nationwide, in Southern California at Albertson’s in the Diet/Diabetic section and Ralph’s in the Adult Nutrition section, in Arizona at Hi-health, in the Midwest at Hy-Vee and online at www.extendbar.com or at 800-887-2919.

If you’d like more information about this topic, or to schedule an interview, please contact Jonathan Lindberg, (314) 336-0587 x 327 or jlindberg@extendbar.com.

Children’s Hospital Los Angeles holds patents and/or patent applications on the underlying technology of ExtendBar®, which it has licensed to Clinical Products Ltd. Francine R. Kaufman, M.D., holds stock in, and is a consultant for, Clinical Products Ltd. Childrens Hospital Los Angeles and Dr. Kaufman benefit financially from the sales of ExtendBar®.